Influence of sex on outcomes of liver transplantation for hepatocellular carcinoma: a multicenter cohort study in China.

IF 5.6 2区 医学 Q1 MEDICINE, RESEARCH & EXPERIMENTAL Cancer Biology & Medicine Pub Date : 2024-02-28 DOI:10.20892/j.issn.2095-3941.2023.0453
Jian Chen, Zhe Yang, Fengqiang Gao, Zhisheng Zhou, Junli Chen, Di Lu, Kai Wang, Meihua Sui, Zhengxin Wang, Wenzhi Guo, Guoyue Lyu, Haizhi Qi, Jinzhen Cai, Jiayin Yang, Shusen Zheng, Xiao Xu
{"title":"Influence of sex on outcomes of liver transplantation for hepatocellular carcinoma: a multicenter cohort study in China.","authors":"Jian Chen, Zhe Yang, Fengqiang Gao, Zhisheng Zhou, Junli Chen, Di Lu, Kai Wang, Meihua Sui, Zhengxin Wang, Wenzhi Guo, Guoyue Lyu, Haizhi Qi, Jinzhen Cai, Jiayin Yang, Shusen Zheng, Xiao Xu","doi":"10.20892/j.issn.2095-3941.2023.0453","DOIUrl":null,"url":null,"abstract":"<p><strong>Objective: </strong>Sex-specific differences are observed in various liver diseases, but the influence of sex on the outcomes of hepatocellular carcinoma (HCC) after liver transplantation (LT) remains to be determined. This study is the first Chinese nationwide investigation of the role of sex in post-LT outcomes in patients with HCC.</p><p><strong>Methods: </strong>Data for recipients with HCC registered in the China Liver Transplant Registry between January 2015 and December 2020 were analyzed. The associations between donor, recipient, or donor-recipient transplant patterns by sex and the post-LT outcomes were studied with propensity score matching (PSM). The survival associated with different sex-based donor-recipient transplant patterns was further studied.</p><p><strong>Results: </strong>Among 3,769 patients enrolled in this study, the 1-, 3-, and 5-year overall survival (OS) rates of patients with HCC after LT were 96.1%, 86.4%, and 78.5%, respectively, in female recipients, and 95.8%, 79.0%, and 70.7%, respectively, in male recipients after PSM (<i>P</i> = 0.009). However, the OS was comparable between recipients with female donors and male donors. Multivariate analysis indicated that male recipient sex was a risk factor for post-LT survival (HR = 1.381, <i>P</i> = 0.046). Among the donor-recipient transplant patterns, the male-male donor-recipient transplant pattern was associated with the poorest post-LT survival (<i>P</i> < 0.05).</p><p><strong>Conclusions: </strong>Our findings highlighted that the post-LT outcomes of female recipients were significantly superior to those of male recipients, and the male-male donor-recipient transplant pattern was associated with the poorest post-LT survival. Livers from male donors may provide the most benefit to female recipients. Our results indicate that sex should be considered as a critical factor in organ allocation.</p>","PeriodicalId":9611,"journal":{"name":"Cancer Biology & Medicine","volume":" ","pages":""},"PeriodicalIF":5.6000,"publicationDate":"2024-02-28","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11033715/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Cancer Biology & Medicine","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.20892/j.issn.2095-3941.2023.0453","RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"MEDICINE, RESEARCH & EXPERIMENTAL","Score":null,"Total":0}
引用次数: 0

Abstract

Objective: Sex-specific differences are observed in various liver diseases, but the influence of sex on the outcomes of hepatocellular carcinoma (HCC) after liver transplantation (LT) remains to be determined. This study is the first Chinese nationwide investigation of the role of sex in post-LT outcomes in patients with HCC.

Methods: Data for recipients with HCC registered in the China Liver Transplant Registry between January 2015 and December 2020 were analyzed. The associations between donor, recipient, or donor-recipient transplant patterns by sex and the post-LT outcomes were studied with propensity score matching (PSM). The survival associated with different sex-based donor-recipient transplant patterns was further studied.

Results: Among 3,769 patients enrolled in this study, the 1-, 3-, and 5-year overall survival (OS) rates of patients with HCC after LT were 96.1%, 86.4%, and 78.5%, respectively, in female recipients, and 95.8%, 79.0%, and 70.7%, respectively, in male recipients after PSM (P = 0.009). However, the OS was comparable between recipients with female donors and male donors. Multivariate analysis indicated that male recipient sex was a risk factor for post-LT survival (HR = 1.381, P = 0.046). Among the donor-recipient transplant patterns, the male-male donor-recipient transplant pattern was associated with the poorest post-LT survival (P < 0.05).

Conclusions: Our findings highlighted that the post-LT outcomes of female recipients were significantly superior to those of male recipients, and the male-male donor-recipient transplant pattern was associated with the poorest post-LT survival. Livers from male donors may provide the most benefit to female recipients. Our results indicate that sex should be considered as a critical factor in organ allocation.

查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
中国多中心队列研究:性别对肝细胞癌肝移植疗效的影响。
目的:各种肝脏疾病均存在性别差异,但性别对肝细胞癌(HCC)肝移植术后预后的影响仍有待确定。本研究是中国首次在全国范围内调查性别对 HCC 患者肝移植后预后的影响:方法:分析了2015年1月至2020年12月期间在中国肝移植登记处登记的HCC受者数据。采用倾向得分匹配法(PSM)研究了不同性别的供体、受体或供体-受体移植模式与肝移植术后结局之间的关系。此外,还进一步研究了与不同性别的供体-受体移植模式相关的存活率:结果:在这项研究登记的 3,769 名患者中,女性受者在 LT 后的 1 年、3 年和 5 年总生存率(OS)分别为 96.1%、86.4% 和 78.5%,男性受者在 PSM 后的 1 年、3 年和 5 年总生存率(OS)分别为 95.8%、79.0% 和 70.7%(P = 0.009)。然而,女性供体和男性供体受体的手术时间相当。多变量分析表明,男性受者的性别是影响长程移植后存活率的一个危险因素(HR = 1.381,P = 0.046)。在供体-受体移植模式中,男性-男性供体-受体移植模式与最差的LT后存活率相关(P < 0.05):我们的研究结果表明,女性受者的移植后疗效明显优于男性受者,而男性-男性供体-受体移植模式与最差的移植后存活率有关。男性捐献者的肝脏可能会给女性受者带来最大益处。我们的研究结果表明,性别应被视为器官分配的关键因素。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
Cancer Biology & Medicine
Cancer Biology & Medicine Medicine-Oncology
CiteScore
9.80
自引率
3.60%
发文量
1143
审稿时长
12 weeks
期刊介绍: Cancer Biology & Medicine (ISSN 2095-3941) is a peer-reviewed open-access journal of Chinese Anti-cancer Association (CACA), which is the leading professional society of oncology in China. The journal quarterly provides innovative and significant information on biological basis of cancer, cancer microenvironment, translational cancer research, and all aspects of clinical cancer research. The journal also publishes significant perspectives on indigenous cancer types in China.
期刊最新文献
Local consolidative therapy in oligometastatic non-small-cell lung cancer after effective systemic treatment: who will benefit? Safety and efficacy of intraoperative radiation therapy using a low-energy X-ray source for resectable pancreatic cancer: an interim evaluation of an ongoing prospective phase II study. Treatment strategies for advanced neuroendocrine neoplasms: current status and future prospects. Advancing precision medicine: the transformative role of artificial intelligence in immunogenomics, radiomics, and pathomics for biomarker discovery and immunotherapy optimization. Multifaceted efforts of governments, medical institutions, and financial organizations contribute to reducing the health inequality caused by economic differences.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1